Clinical Research Core

临床研究核心

基本信息

  • 批准号:
    8135412
  • 负责人:
  • 金额:
    $ 8.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

The goals of the cliniclal research core are to provide all projects with centralized clinical trial support and provide an infrastructure of personnel and services that will adequately support such research. Core services will be provided in regulatory affairs, study coordination, quality assurance and control and data safety monitoring. The Regulatory Affairs component collaborates with investigators to develop and submit all required regulatory documents, including submissions to the IRB, IBC, FDA, and NIH/ORDA and annual reports. This core has extensive experience with IND submission and currently supports over 25 IND studies. The Quality Control (QC) program will ensure that standard operating procedures for protocol development, conduct of clinical trials, data collection and management of clinical trials are accurately defined and being followed. The QA program will undertake audits after the first patient is enrolled on a study and then randomly to ensure that the studies are being conducted according to Good Clinical Practices. The core will also co-ordinate data monitoring by the Data Review Committee which is responsible for reviewing and evaluating toxicity and any other study-relevant safety-related data for clinical research studies in this SPORE. The core will also arrange internal group meetings of the investigators, attending physicians, statisticians, research nurse, data manager, and appropriate nurse managers to ensure that the clinical studies are conducted both safely and efficiently. It will also provide research nurse support to faciliate conduct of clinical trials.
临床研究中心的目标是为所有项目提供集中的临床试验支持和

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HELEN E HESLOP其他文献

HELEN E HESLOP的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HELEN E HESLOP', 18)}}的其他基金

Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
抗病毒和抗白血病 T 细胞治疗作为 HSCT 后的预防
  • 批准号:
    9069027
  • 财政年份:
    2011
  • 资助金额:
    $ 8.15万
  • 项目类别:
Anti-viral and antileukemic T-cell therapy as prophylaxis after HSCT
抗病毒和抗白血病 T 细胞治疗作为 HSCT 后的预防
  • 批准号:
    8479213
  • 财政年份:
    2011
  • 资助金额:
    $ 8.15万
  • 项目类别:
MOST CLOSELY HLA MATCHED ALLOGENEIC VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL)
HLA 最接近匹配的同种异体病毒特异性细胞毒性 T 淋巴细胞 (CTL)
  • 批准号:
    8356704
  • 财政年份:
    2010
  • 资助金额:
    $ 8.15万
  • 项目类别:
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI
临床试验:对 RECIPI 施用 EBV 特异性细胞毒性 T 淋巴细胞
  • 批准号:
    8356760
  • 财政年份:
    2010
  • 资助金额:
    $ 8.15万
  • 项目类别:
Enhancing T Cell Therapy of Cancer
增强癌症 T 细胞治疗
  • 批准号:
    7845205
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:
CLINICAL TRIAL: ADMINISTRATION OF EBV SPECIFIC CYTOTOXIC T LYMPHOCYTES TO RECIPI
临床试验:对 RECIPI 施用 EBV 特异性细胞毒性 T 淋巴细胞
  • 批准号:
    8166752
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:
CLINICAL TRIAL: AUTOLOGOUS EBV SPECIFIC CTLS FOR THERAPY OF SEVERE CHRONIC EBV I
临床试验:自体 EBV 特异性 CTLS 用于治疗严重慢性 EBV I
  • 批准号:
    8166754
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:
MOST CLOSELY HLA MATCHED ALLOGENEIC VIRUS SPECIFIC CYTOTOXIC T-LYMPHOCYTES (CTL)
HLA 最接近匹配的同种异体病毒特异性细胞毒性 T 淋巴细胞 (CTL)
  • 批准号:
    8166725
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:
CLINICAL TRIAL: EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES FOR EBV-POSITIVE NASOPHARYN
临床试验:针对 EBV 阳性鼻咽的 EBV 特异性细胞毒性 T 淋巴细胞
  • 批准号:
    8166756
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:
PROCUREMENT OF TISSUE FOR MAKING EPSTEIN-BARR VIRUS (EBV) SPECIFIC CYTOTOXIC T
采购用于制备 Epstein-Barr 病毒 (EBV) 特异性细胞毒性 T 的组织
  • 批准号:
    8166709
  • 财政年份:
    2009
  • 资助金额:
    $ 8.15万
  • 项目类别:

相似海外基金

The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 8.15万
  • 项目类别:
CAPRISA CASCADE Clinical Trials Network Clinical Research Site
CAPRISA CASCADE 临床试验网络临床研究网站
  • 批准号:
    10754981
  • 财政年份:
    2023
  • 资助金额:
    $ 8.15万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10617997
  • 财政年份:
    2022
  • 资助金额:
    $ 8.15万
  • 项目类别:
TO PROVIDE BIO-MEDICAL AND BEHAVIORAL RESEARCH RESOURCES AND CLINICAL RESEARCH COORDINATING SERVICES TO SUPPORT THE NIDA CLINICAL TRIALS NETWORK (CTN)
提供生物医学和行为研究资源以及临床研究协调服务以支持 NIDA 临床试验网络 (CTN)
  • 批准号:
    10538151
  • 财政年份:
    2021
  • 资助金额:
    $ 8.15万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10624966
  • 财政年份:
    2021
  • 资助金额:
    $ 8.15万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10515803
  • 财政年份:
    2021
  • 资助金额:
    $ 8.15万
  • 项目类别:
Health 360x Clinical Research Platform for Scalable Access to Clinical Trials
Health 360x 临床研究平台可扩展临床试验的访问
  • 批准号:
    10258627
  • 财政年份:
    2021
  • 资助金额:
    $ 8.15万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10581505
  • 财政年份:
    2019
  • 资助金额:
    $ 8.15万
  • 项目类别:
New Mexico Clinical Trials Node: Clinical research and practice to address substance use in diverse, rural and underserved populations
新墨西哥州临床试验节点:解决多样化、农村和服务不足人群的药物使用问题的临床研究和实践
  • 批准号:
    10379715
  • 财政年份:
    2019
  • 资助金额:
    $ 8.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了